Noxon closes seed funding round to advance muscle-computer interface technology

March 2, 2026 at 06:14 AM UTC
Tech.eu
Original: EN
Noxon closes seed funding round to advance muscle-computer interface technology

Munich-based medtech firm Noxon has successfully secured seed funding, led by High-Tech Gründerfonds and Bayern Kapital, with additional investment from Auxxo and another institutional backer. This funding injection is set to accelerate the development of their innovative Muscle-Computer Interface (MCI) technology, addressing a significant gap in the treatment of neuromuscular disorders. The investment underscores growing European interest in advanced health-tech solutions that offer personalized and continuous patient care. Noxon's MCI technology directly tackles the limitations of intermittent muscle diagnostics and activation currently prevalent in clinical settings. Their wearable solution integrates continuous muscle diagnostics with neuromuscular electrical stimulation (NMES), creating a closed feedback loop. This allows for real-time data acquisition and personalized muscle and nerve activation, adaptable for everyday use through various formats like tapes, patches, and orthopaedic aids. The potential impact of Noxon's technology spans across rehabilitation and the treatment of neuromuscular conditions. By providing patients with continuous data and adaptive therapy, the MCI promises to enhance treatment efficacy and patient outcomes. Furthermore, collaborations with institutions like University Hospital Würzburg are exploring pilot applications for conditions like Parkinson's, aiming to improve muscle control where brain-to-muscle signal transmission is compromised.

Curated and translated by Europe Digital for our multilingual European audience.

Source Information

Publication: Tech.eu
Published: March 2, 2026 at 06:14 AM UTC
All rights remain with the original publisher.